Advances in myocardial protection: The role of mechanical devices in providing cardioprotective strategies

International Anesthesiology Clinics

Volumn 34, Issue 2, 1996, Pages 61-84

  Stammers, Alfred H ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT;

ANESTHESIA COMPLICATION; ANESTHETIC EQUIPMENT; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; HEART CATHETER; HEART PERFUSION; HEART PROTECTION; HEART SURGERY; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0029920128     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199603420-00007     Document Type: Review

References (66)

1. Melrose DG, Dreyer B, Bentall HH, et al. Elective cardiac arrest. Lancet 1955;2:21-22
2. Effler DB, Groves LK. Elective potassium arrest with potassium citrate. Acetylcholine-induced asystole. In: Allen JG, ed. Extracorporeal Circulation. Springfield: Charles C Thomas, 1958:459-465
3. Ebert PA. Aspects of myocardial protection. Ann Thorac Surg 1978;26:495-496
4. Demmy TL, Haggerty SP, Boley TM, Curds JJ. Lack of cardioplegia uniformity in clinical myocardial preservation. Ann Thorac Surg 1994;57:648-651
5. Hearse DJ, Bramimbridge MV, Jynge P. Protection of the Ischemic Myocardium. New York: Raven Press, 1981:151-299
6. Mauney MC, Kron IL. The physiologic basis of warm cardioplegia. Ann Thorac Surg 1995;60:819-823
7. Ringer S. Further contribution regarding influence of different constituents of blood on contraction of the heart. J Physiol 1883;4:29-42
8. Lam CR, Gahagan T, Sergeant C, Green E, Acetylcholine-induced asystole. In: Alien JG, ed. Extracorporeal Circulation, Springfield, Ill: Charles C Thomas, 1958:451-458
9. Lillehei CW, DeWall RA, Gott VL, et al. The direct vision correlation of calcific aortic stenosis by means of a pump-oxygenator and retrograde coronary sinus perfusion. Dis Chest 1956;30:123-132
10. Kirsch V, Rodewald G, Kalamar P. Induced ischemic arrest: clinical experience with cardioplegia in open-heart surgery. J Thorac Cardiovasc Surg 1972;63:121-130
11. Bretschneider H, Hugner G, Knoll D, et al. Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Thorac Cardiovasc Surg 1975;16:241-260
12. MacFarland JA, Thomas LB, Gilbert JW, Morrow AG. Myocardial necrosis following elective cardiac arrest with potassium citrate. Surgery 1960;40:200-208
13. Gay WA, Ebert PA. Functional, metabolic and morphological effects of potassium-induced cardioplegia. Surgery 1973;74;284-290
14. Tyers GFO, Hughes HC, Todd GJ, et al. Protection from ischemic cardiac arrest by coronary perfusion with cold Ringer's lactate solution. J Thorac Cardiovasc Surg 1974;67:411-418
15. Molina JE, Gani KS, Voss DM. Pressurized rapid cardioplegia versus administration of exogenous substrate and topical hypothermia. Ann Thorac Surg 1982;33:434-444
16. Mitchell BA, Litwak RS. Myocardial protection with cold, ischemic potassium-induced cardioplegia: an overview. Proc Am Soc Extra-Corporeal Tech 1978;6:127-130
17. Vertrees RA, Auvil J, Rousou JH, Engelman RM. A technique of myocardial preservation perfusion. Ann Thorac Surg 1979;78:601-602
18. Grover FL, Fewel JG, Ghidoni JJ, et al. Comparison of roller pump versus pressur- ized bag administration of potassium cardioplegic solution. Ann Thorac Surg 1982;34:278-286
19. Johnson RE, Dorsery LM, Moye SJ, et al. Cardioplegia infusion: the safe limits of pressure and temperature. J Thorac Cardiovasc Surg 1982;83:813-823
20. Stammers AH. Extracorporeal devices and related technologies. In: Kaplan JA, ed. Cardiac Anesthesia. Philadelphia: W.B. Saunders, 1993:995-1029
21. Chitwood WR. Retrograde cardioplegia: current methods. Ann Thorac Surg 1992;53:352-355
22. Voci P, Bilotta F, Caretta F, et al. Mechanisms of incomplete cardioplegia distribution during coronary artery bypass grafting. Anesthesiology 1993;79:904-912
23. Moisa RB, Zeldis SM, Alper SA, Scott WC. Aortic regurgitation in coronary artery bypass grafting: implications for cardioplegic administration, Ann Thorac Surg 1995;60:665-668
24. Menasche P, Koral S, Fauchest M, et al. Retrograde coronary sinus perfusion: a safe alternative for ensuring cardioplegic delivery in aortic valve surgery. Ann Thorac Surg 1982;34:647-658
25. Quintilio C, Voci P, Bilotta F, et al. Risk factors of incomplete distribution of cardioplegic solution during coronary artery grafting. J Thorac Cardiovasc Surg 1995;109:439-447
26. Gundry SR, Kirsh MM. A comparison of retrograde cardioplegia versus antegrade cardioplegia in the presence of coronary artery obstruction. Ann Thorac Surg 1984;38:124-127
27. Menasche P, Piwnica A. Cardioplegia by the way of the coronary sinus for valvular and coronary surgery. J Am Coll Cardiol 1991;18:628-636
28. Ardehali A, Laks H, Drinkwater DC, et al. Ventricular effluent of retrograde cardioplegia in human hearts has traversed capillary beds. Ann Thorac Surg 1995;60:78-83
29. Ardehali A, Gates RN, Laks H, et al. The regional capillary distribution of retrograde cardioplegia in explanted human hearts. J Thorac Cardiovasc Surg 1995;109:935-940
30. Menasche P, Tronc F, Nguyen A, et al. Retrograde warm blood cardioplegia preserves hypertrophied myocardium: a clinical study. Ann Thorac Surg 1994;57:1429-1434
31. Menasche P. Experimental comparison of manually inflatable versus autoinflatable retrograde cardioplegia catheters. Ann Thorac Surg 1994;58:533-535
32. Buckberg GD. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989;4:216-238
33. Robinson LA, Schwarz GD, Goddard DB, et al. Myocardial protection for acquired heart disease surgery: results of a national survery. Ann Thorac Surg 1995;59:361-372
34. Ihnken K, Morita K, Buckberg GD, et al. The safety of simultaneous antegrade and coronary sinus perfusion: experimental background and initial clinical results. J Card Surg 1994;9:15-25
35. Zaroff J, Aronson S, Lee BK, et al. The relationship between immediate outcome after cardiac surgery, homogeneous cardioplegia delivery, and ejection fraction. Chest 1994;106:38-45
36. Curtis JJ, Walls JT, Boley T, et al. The effect of myocardial preservation technique on operative mortality in complex valvular disease. J Cardiovasc Surg Torino 1985;26:231-235
37. Lazar HL, Robert AJ. Recent advances in cardiopulmonary bypass and the clinical application of myocardial protection. Surg Clin North Am 1985;65:455-476
38. Rabinov M, Chen XZ, Rosenfeldt FL. Comparison of the metabolic response of the hypertrophic and the normal heart to hypothermic cardioplegia. The effect of temperature. J Thorac Cardiovasc Surg 1989;97:43-49
39. Fleisher AG, Sarabu MR, Reed GE. Repair of coronary sinus rupture secondary to retrograde cardioplegia. Ann Thorac Surg 1994;57:476-478
40. Weiss SJ. Management of difficult coronary sinus rupture. Ann Thorac Surg 1994;58:548-550
41. Ikonomidis JS, Yau IM, Weisel RD, et al. Optimal flow rates for retrograde warm cardioplegia. J Thorac Cardiovasc Surg 1994;107:510-519
42. Baker AJ, Naser B, Benaroia M, Mazer CD. Cerebral microembolic during coronary artery bypass using different cardioplegia techniques. Ann Thorac Surg 1995;59:1187-1191
43. Ellis RJ, Mavroudis C, Gardner C, et al. Relationship between atrioventricular arrhythmias and concentration of potassium ion in cardioplegic solutions. J Thorac Cardiovasc Surg 1980;80:517-526
44. Rousou JH, Engelman RM, Dobbs WA, Lemeshow S. The optimal potassium concentration in cardioplegic solutions. Ann Thorac Surg 1981;32:75-79
45. Schwabe JL, Sugimoto JT, Rothberg ML. Simple method of cardioplegia retrieval in patients with chronic renal failure. Ann Thorac Surg 1993;55:1240-1241
46. Dewar M, Rosengarten MD, Samson R, et al. Is high potassium solution necessary for reinfusions in "multidose" cold cardioplegia? Ann Thorac Surg 1987;43:409-415
47. Chiavarelli M, Fabi F, Stati T, et al. Effects of cardioplegic solutions and their components on human saphenous vein contractility. Ann Thorac Surg 1992;53:455-459
48. Keller MW, Geddes L, Spotnitz W, et al. Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion. Effects of adenosine. Circulation 1991;84:2485-2494
49. Ihnken K, Morita K, Buckberg GD. New approaches to blood cardioplegic delivery to reduce hemodilution and cardioplegic overdose. J Card Surg 1994;9:26-36
50. Menasche P. Warm cardioplegia or aerobic cardioplegia: let's call a spade a spade. Ann Thorac Surg 1994;58:5-6
51. Christakis GT, Fremes SE, Koch JP, et al. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg 1994;58:1040-1049
52. Chen YF, Lin YT, Wu SC. Inconsistent effectiveness of myocardial preservation among cardiac chambers during hypothermic cardioplegia. J Thorac Cardiovasc Surg 1991;102:684-687
53. Avery MD, Ybarra J, Estrello R, et al. Effects of varied cardioplegic perfusion pressure on myocardial preservation with critical coronary stenosis. Ann Thorac Surg 1985;40:469-474
54. Holman WL, Spruell RD, Palcifinco AD. Duration of asystolic reperfusion and reperfusate electrolyte composition influence post cardioplegia ventricular fibrillation. J Thorac Cardiovasc Surg 1993;106:511-519
55. Swanson DK, Myerowitz PD. Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts. J Thorac Cardiovasc Surg 1983;86:242-251
56. Metzdorff MT, Grunkemeier GL, Starr A. Effect of initial reperfusion temperature on myocardial preservation. J Thorac Cardiovasc Surg 1986;91:545-550
57. Yamada M, Hearse DJ, Curtis MJ. Reperfusion and readmission of oxygen. Circulation Res 1990;67:1211-1224
58. Beyersdorf F, Sarai K, Maul FD, et al. Immediate functional benefits after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg 1991;102:856-866
59. Naylor CD, Lichtenstein SV, Fremes SE, et al. Randomized trial of normothermic versus hypothermic coronary bypass surgery. Lancet 1994;343:559-563
60. Mikaeloff P, Jegaden O, Montagna P, et al. Is continuous warm retrograde blood cardioplegia completely safe for coronary artery surgery? Eur J Cardiothorac Surg 1994;8;560-574
61. Hughes CF, Grant AF, Leckie BD, Baird DK. Cardioplegic solution: a contamination crisis. J Thorac Cardiovasc Surg 1986;91:296-302
62. Robinson LA, Braimbridge MV, Hearse DJ. The potential hazard of particulate contamination of cardioplegic solutions. J Thorac Cardiovasc Surg 1984;87:48-58
63. Hearse DJ, Erol C, Robinson LR, et al. Particle-induced coronary vasoconstriction during cardioplegic solution. J Thorac Cardiovasc Surg 1985;89:428-438
64. Palanzo DA, O'Neill MJ, Harrison LH. An effective 0.2 micron filter for the administration of cardioplegia. Proc Am Acad Cardiovasc Perf 1987;8:182-185
65. Sawa Y, Matsuda H, Shimazaki Y, et al. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108:1125-1131
66. Hyman WA. Increased safety in perfusion through integrated design. Perf Life 1995;12:28-31